Borman Andrew M, Fraser Mark, Palmer Michael D, Szekely Adrien, Houldsworth Marian, Patterson Zoe, Johnson Elizabeth M
Public Health England United Kingdom, Mycology Reference Laboratory, Myrtle Road, Bristol BS2 8EL, UK.
J Fungi (Basel). 2017 May 31;3(2):27. doi: 10.3390/jof3020027.
For filamentous fungi (moulds), species-specific interpretive breakpoints and epidemiological cut-off values (ECVs) have only been proposed for a limited number of fungal species-antifungal agent combinations, with the result that clinical breakpoints are lacking for most emerging mould pathogens. In the current study, we have compiled minimum inhibitory concentration (MIC) data for 4869 clinical mould isolates and present full MIC distributions for amphotericin B, itraconazole, voriconazole, posaconazole, and caspofungin with these isolates which comprise 20 species/genera. In addition, we present the results of an assessment of the fungicidal activity of these same five antifungal agents against a panel of 123 mould isolates comprising 16 of the same species.
对于丝状真菌(霉菌),仅针对有限数量的真菌种类与抗真菌药物组合提出了种属特异性的解释性断点和流行病学截断值(ECV),结果是大多数新兴霉菌病原体缺乏临床断点。在本研究中,我们汇总了4869株临床霉菌分离株的最低抑菌浓度(MIC)数据,并给出了两性霉素B、伊曲康唑、伏立康唑、泊沙康唑和卡泊芬净对这些包含20个种/属的分离株的完整MIC分布。此外,我们还给出了这五种抗真菌药物对一组包含16个相同种类的123株霉菌分离株的杀菌活性评估结果。